- Debette S, Visvikis-Siest S, Chen M-H, Ndiaye N-C, Song C, Destefano A, et al. Identification of cis-and transacting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.
Circulation research. 2.554-63:)5(109;011
2. Bertrand M-J, Tardif J-C. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
Expert opinion on emerging drugs. 2017;22(1):1-26.
3. Amerzadeh M, Salavati S, Takian A, Namaki S, Asadi-Lari M, Delpisheh A, et al. Proactive agenda setting in
creation and approval of national action plan for prevention and control of non-communicable diseases in Iran: The
use of multiple streams model. Journal of Diabetes & Metabolic Disorders. 2020:1-12.
4. Dessì M ,Noce A, Bertucci P, Manca di Villahermosa S, Zenobi R, Castagnola V, et al. Atherosclerosis,
dyslipidemia, and inflammation: the significant role of polyunsaturated fatty acids. ISRN inflammation. 2013;2013.
5. Kotur-Stevuljevic J, Memon L, Stefanovic A ,Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, et al.
Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clinical
biochemistry. 2007;40(3-4):181-7.
6. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood, The Journal of the American Society of
Hematology. 1997;90(1):1-11.
7. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. Bmj. 2002;325(7374):1202.
8. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
The Journal of clinical investigation. 1976;57(4):1079-82.
9. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and
mortality in patients with coronary artery disease. New England Journal of Medicine. 1997;337(4):230-7.
10. Mei W, Rong Y, Jinming L, Yongjun L, Hui Z. Effect of homocysteine interventions on the risk of
cardiocerebrovascular events: a meta‐analysis of randomised controlled trials. International journal of clinical
practice. 2010;64(2):208-15.
11. Clarke R, Collins R, Lewington S, Donald A, Alfthan G, Tuomilehto J, et al. Homocysteine and risk of ischemic
heart disease and stroke: a meta-analysis. Journal of the American Medical Association. 2002;288(16):2015-22.
12. Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini
review. Expert review of cardiovascular therapy. 2018;16(8):559-65.
13. Kim J, Kim H, Roh H, Kwon Y. Causes of hyperhomocysteinemia and its pathological significance. Archives of
pharmacal research. 2018;41(4):372-83.
14. Mirdamadi A, Farzamnia H, Varzandeh P, Almasi N, Arasteh M. Association between serum homocysteine
concentration with coronary artery disease in Iranian patients. ARYA atherosclerosis. 2011;7(2):63.
15. Zhang S, Bai Y-Y, Luo L-M, Xiao W-K, Wu H-M, Ye P. Association between serum homocysteine and arterial
stiffness in elderly: a community-based study. Journal of geriatric cardiology: JGC. 2014;11(1):32.
16. Schaffer A, Verdoia M, Cassetti E, Marino P, Suryapranata H, De Luca G, et al. Relationship between homocysteine
and coronary artery disease. Results from a large prospective cohort study. Thrombosis research288-:)2(134;2014 .
.93
17. Shenoy V, Mehendale V, Prabhu K, Shetty R, Rao P. Correlation of serum homocysteine levels with the severity
of coronary artery disease. Indian Journal of Clinical Biochemistry. 2014;29(3):339-44.
18. Dudman NP, Temple SE, Guo XW ,Fu W, Perry MA. Homocysteine enhances neutrophil-endothelial interactions
in both cultured human cells and rats in vivo. Circulation research. 1999;84(4):409-16.
19. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine
are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. The Journal of clinical
investigation. 1993;91(1):308-18.
20. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocyst (e )ine and cardiovascular
disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control
studies. International journal of epidemiology. 2002;31(1):59-70.
21. Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, et al. Effects of homocysteinelowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction
survivors: a randomized trial. Jama. 2010;303(24):2486-94.
22. Martí‐Carvajal AJ, Sola I ,Lathyris D, Dayer M. Homocysteine‐lowering interventions for preventing
cardiovascular events. Cochrane Database of Systematic Reviews. 2017(8.)
23. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M, editors. Homocysteine level and coronary heart disease
incidence: a systematic review and meta-analysis. Mayo Clinic Proceedings; 2008: Elsevier.
- 24. Mirblok, Fardin, Salari, Arsalan, Rezaeidanesh, Maedeh, et al. Relationship between plasma homocysteine and the
severity of coronary artery disease in patients with coronary angiography. Journal of Guilan University of Medical
Sciences.57-66:)2(24;2015 .
25. Bilsborough W, Green DJ, Mamotte CD, van Bockxmeer FM, O'Driscoll GJ, Taylor RR. Endothelial nitric oxide
synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function. Atherosclerosis.
2003;169.131-8:)1(
26. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial
dysfunction produced by experimental hyperhomocyst (e) inemia in humans. Circulation. 1999;100(11):1161-8.
27. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine
in coronary artery disease. Clinical chemistry. 2001;47(5):887-92.
28. Løland KH, Bleie Ø, Blix AJ, Strand E, Ueland PM, Refsum H, et al. Effect of homocysteine-lowering B vitamin
treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial
(WENBIT) substudy. The American journal of cardiology. 2010;105(11):1577-84.
29. El Assar De La Fuente M, Angulo Frutos J, Vallejo Fernán S, Peiró Vallejo C, Sánchez-Ferrer CF, RodríguezMañas L. Mechanisms involved in the aging-induced vascular dysfunction. Frontiers in physiology. 2012;3:132.
30. Leipsic J, Taylor CM, Gransar H, Shaw LJ, Ahmadi A, Thompson A, et al. Sex-based prognostic implications of
nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology.
2014;273(2):393-400.
31. She J, Deng Y, Wu Y, Xia Y, Li H, Liang X, et al. Hemoglobin A 1c is associated with severity of coronary artery
stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial
infarction undergoing primary angioplasty. Cardiovascular diabetology. 2017;16(1):1-8.
32. Yan AT, Koh M, Chan KK, Guo H, Alter DA, Austin PC, et al. Association between cardiovascular risk factors and
aortic stenosis: the CANHEART Aortic Stenosis Study. Journal of the American College of Cardiology.
2017;69(12):1523-32.
|
